$EKSO
EKSO BIONICS HOLDINGS, INC.

2021 Q2 Form 10-Q Financial Statement

#000154908421000039 Filed on July 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $2.211M $2.264M
YoY Change -2.34% -30.59%
Cost Of Revenue $919.0K $1.005M
YoY Change -8.56% -40.95%
Gross Profit $1.292M $1.259M
YoY Change 2.62% -19.29%
Gross Profit Margin 58.44% 55.61%
Selling, General & Admin $3.931M $3.655M
YoY Change 7.55% -29.15%
% of Gross Profit 304.26% 290.31%
Research & Development $709.0K $452.0K
YoY Change 56.86% -69.85%
% of Gross Profit 54.88% 35.9%
Depreciation & Amortization $143.0K $160.0K
YoY Change -10.63% -33.33%
% of Gross Profit 11.07% 12.71%
Operating Expenses $4.640M $4.351M
YoY Change 6.64% -34.65%
Operating Profit -$3.348M -$3.092M
YoY Change 8.28% -39.35%
Interest Expense $27.00K $38.00K
YoY Change -28.95% -64.49%
% of Operating Profit
Other Income/Expense, Net $2.075M -$8.675M
YoY Change -123.92% -526.92%
Pretax Income -$4.943M -$11.77M
YoY Change -58.0% 283.39%
Income Tax
% Of Pretax Income
Net Earnings -$1.273M -$11.77M
YoY Change -89.18% 283.79%
Net Earnings / Revenue -57.58% -519.74%
Basic Earnings Per Share -$0.10 -$1.88
Diluted Earnings Per Share -$0.11 -$1.88
COMMON SHARES
Basic Shares Outstanding 12.66M shares 6.261M shares
Diluted Shares Outstanding 12.74M shares 6.261M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.94M $13.26M
YoY Change 246.44% 0.0%
Cash & Equivalents $45.94M $13.26M
Short-Term Investments
Other Short-Term Assets $648.0K $530.0K
YoY Change 22.26% -13.11%
Inventory $1.953M $2.384M
Prepaid Expenses
Receivables $2.756M $3.741M
Other Receivables $0.00 $0.00
Total Short-Term Assets $51.30M $19.91M
YoY Change 157.63% -10.04%
LONG-TERM ASSETS
Property, Plant & Equipment $1.059M $1.248M
YoY Change -15.14% -31.28%
Goodwill $189.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $163.0K $117.0K
YoY Change 39.32% -30.36%
Total Long-Term Assets $1.678M $2.439M
YoY Change -31.2% -29.3%
TOTAL ASSETS
Total Short-Term Assets $51.30M $19.91M
Total Long-Term Assets $1.678M $2.439M
Total Assets $52.97M $22.35M
YoY Change 137.03% -12.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.428M $1.902M
YoY Change -24.92% -23.31%
Accrued Expenses $1.317M $1.180M
YoY Change 11.61% -57.37%
Deferred Revenue $1.422M $1.345M
YoY Change 5.72% -1.75%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.430M
YoY Change -100.0% 4.16%
Total Short-Term Liabilities $4.681M $7.129M
YoY Change -34.34% -23.7%
LONG-TERM LIABILITIES
Long-Term Debt $1.991M $640.0K
YoY Change 211.09% -58.31%
Other Long-Term Liabilities $53.00K $29.00K
YoY Change 82.76% -35.56%
Total Long-Term Liabilities $2.044M $29.00K
YoY Change 6948.28% -98.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.681M $7.129M
Total Long-Term Liabilities $2.044M $29.00K
Total Liabilities $12.88M $22.38M
YoY Change -42.45% 10.89%
SHAREHOLDERS EQUITY
Retained Earnings -$204.0M -$197.6M
YoY Change 3.27% 9.3%
Common Stock $13.00K $8.000K
YoY Change 62.5% -89.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.10M -$28.00K
YoY Change
Total Liabilities & Shareholders Equity $52.97M $22.35M
YoY Change 137.03% -12.64%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$1.273M -$11.77M
YoY Change -89.18% 283.79%
Depreciation, Depletion And Amortization $143.0K $160.0K
YoY Change -10.63% -33.33%
Cash From Operating Activities -$3.606M -$4.030M
YoY Change -10.52% -11.04%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.000K 8.750M
YoY Change -99.98% 1.74%
NET CHANGE
Cash From Operating Activities -3.606M -4.030M
Cash From Investing Activities 0.000
Cash From Financing Activities 2.000K 8.750M
Net Change In Cash -3.604M 4.720M
YoY Change -176.36% 17.41%
FREE CASH FLOW
Cash From Operating Activities -$3.606M -$4.030M
Capital Expenditures $0.00
Free Cash Flow -$4.030M
YoY Change -10.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37854
dei Entity Registrant Name
EntityRegistrantName
Ekso Bionics Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
dei Entity Address Address Line1
EntityAddressAddressLine1
1414 Harbour Way South
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1201
dei Entity Address City Or Town
EntityAddressCityOrTown
Richmond
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94804
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
984-1761
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EKSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12655321 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45938000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12862000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2756000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3224000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1953000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1978000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
648000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
356000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
51295000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18420000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1059000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1172000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
456000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
685000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
320000 USD
CY2021Q2 us-gaap Assets
Assets
52973000 USD
CY2020Q4 us-gaap Assets
Assets
20597000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1428000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1501000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1317000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1429000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1422000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1496000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
514000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
548000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4681000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4974000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1526000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1806000 USD
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1991000 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3075000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
233000 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
4626000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
6037000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
12877000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
16163000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12655000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12655000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8349000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8349000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244636000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204376000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-507000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-847000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204046000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-199103000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40096000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4434000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52973000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20597000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2211000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4121000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
919000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1594000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1835000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
1292000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1259000 USD
us-gaap Gross Profit
GrossProfit
2527000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1712000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3580000 USD
us-gaap Gross Profit
GrossProfit
1896000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1787000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4232000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
709000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
452000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1312000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1163000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2144000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1943000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4122000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4130000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
244000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
244000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
4640000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4351000 USD
us-gaap Operating Expenses
OperatingExpenses
9014000 USD
us-gaap Operating Expenses
OperatingExpenses
9769000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3348000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3092000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6487000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7873000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
27000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
38000 USD
us-gaap Interest Expense
InterestExpense
53000 USD
us-gaap Interest Expense
InterestExpense
90000 USD
CY2021Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
875000 USD
CY2020Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-8574000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
886000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-6055000 USD
CY2021Q2 ekso Warrant Issuance Expense
WarrantIssuanceExpense
0 USD
CY2020Q2 ekso Warrant Issuance Expense
WarrantIssuanceExpense
329000 USD
ekso Warrant Issuance Expense
WarrantIssuanceExpense
0 USD
ekso Warrant Issuance Expense
WarrantIssuanceExpense
329000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1099000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1099000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 ekso Other Income Expense
OtherIncomeExpense
128000 USD
CY2020Q2 ekso Other Income Expense
OtherIncomeExpense
266000 USD
ekso Other Income Expense
OtherIncomeExpense
-388000 USD
ekso Other Income Expense
OtherIncomeExpense
46000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2075000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8675000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1544000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6428000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1273000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11767000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4943000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14301000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-125000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-193000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
340000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1398000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11960000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4603000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14321000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.37
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.37
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12655000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6261000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11709000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6032000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12737000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6261000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11839000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6032000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4434000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3670000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35360000 USD
CY2021Q1 ekso Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3878000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
152000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
356000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
465000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40975000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6797000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1273000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
519000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-125000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40096000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2534000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
155000 USD
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
50000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
587000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
173000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5228000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11767000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7082000 USD
CY2020Q2 ekso Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1436000 USD
CY2020Q2 ekso Adjustments To Additional Paid In Capital Warrant Issuance
AdjustmentsToAdditionalPaidInCapitalWarrantIssuance
2322000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
508000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
886000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-193000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-28000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4943000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14301000 USD
us-gaap Depreciation
Depreciation
273000 USD
us-gaap Depreciation
Depreciation
320000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
48000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1099000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-6055000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
329000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
875000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1095000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
23000 USD
ekso Gain Loss On Modification Of Operating Lease Liabilities
GainLossOnModificationOfOperatingLeaseLiabilities
0 USD
ekso Gain Loss On Modification Of Operating Lease Liabilities
GainLossOnModificationOfOperatingLeaseLiabilities
-38000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
66000 USD
ekso Common Stock Contribution
CommonStockContribution
107000 USD
ekso Common Stock Contribution
CommonStockContribution
99000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-372000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-420000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1420000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
136000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-194000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-94000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-73000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1086000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
793000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-306000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-746000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-354000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-230000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5606000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5745000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37295000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7082000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1417000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
785000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38712000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8160000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-30000 USD
us-gaap Interest Paid Net
InterestPaidNet
61000 USD
ekso Fair Value Of Warrants Issued Upon Equity Financing
FairValueOfWarrantsIssuedUponEquityFinancing
1936000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-27000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33076000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2388000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12862000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10872000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45938000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13260000 USD
us-gaap Interest Paid Net
InterestPaidNet
46000 USD
ekso Fair Value Of Warrants Issued Upon Equity Financing
FairValueOfWarrantsIssuedUponEquityFinancing
0 USD
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
2461000 USD
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
0 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
162000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
-89000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
152000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
155000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
50000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204046000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5606000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45938000 USD
CY2021Q2 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
2000000 USD
ekso Unrestricted Cash
UnrestrictedCash
43938000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to, revenue recognition, deferred revenue and the deferral of the associated costs, the valuation of warrants and employee stock options, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, and contingencies. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. The Company extends credit to customers in the normal course of business and performs ongoing credit evaluations of its customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are derived from the sale of products shipped and services performed for customers primarily located in the U.S., Europe, Asia, and Australia. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and provides an allowance for potential credit losses. The Company has not experienced material losses related to accounts receivable as of June 30, 2021 and December 31, 2020. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon settling contracts denominated in a foreign currency.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021, the Company had two customers with an accounts receivable balance totaling 10% or more of the Company’s total accounts receivable (11% and 20%), as compared with two customers at December 31, 2020 (10% and 13%).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, the Company had one customer with sales of 10% or more of the Company’s total revenue (13%), as compared with two customers in the three months ended June 30, 2020 (11% and 13%).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, the Company had one customer with sales of 10% or more of the Company’s total revenue (11%) as compared with no customers during the same period of 2020.</span></div>
ekso Number Of Customers
NumberOfCustomers
2 customer
CY2020 ekso Number Of Customers
NumberOfCustomers
2 customer
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
340000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1441000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1724000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
211000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
18000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
301000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
236000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1953000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1978000 USD
CY2021Q2 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2568000 USD
CY2020Q4 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2902000 USD
CY2021Q2 ekso Deferred Royalties
DeferredRoyalties
280000 USD
CY2020Q4 ekso Deferred Royalties
DeferredRoyalties
282000 USD
CY2021Q2 us-gaap Deferred Revenue Leases Net
DeferredRevenueLeasesNet
100000 USD
CY2020Q4 us-gaap Deferred Revenue Leases Net
DeferredRevenueLeasesNet
118000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2948000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3302000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
839000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1011000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1422000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1496000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1526000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1806000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3302000 USD
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
548000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
902000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2948000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2948000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1098000 USD
CY2021Q2 ekso Contractwith Customer Liability Non Cancellable Backlog
ContractwithCustomerLiabilityNonCancellableBacklog
1348000 USD
CY2021Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P12M
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2756000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3224000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2211000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4121000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1144000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1194000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
146000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
188000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1317000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1429000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45938000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2000000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1991000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1991000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1991000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
301000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
235000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
536000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
514000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y11M8D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
132000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
135000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
265000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
273000 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12655000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12655000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8349000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8349000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1325000 shares
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
273000 shares
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
358000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1240000 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1417000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
785000 USD
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
358000 shares
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-223000 shares
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.02
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
519000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
508000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
875000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1095000 USD
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
50000 USD
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
1267000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1273000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11767000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4943000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14301000 USD
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
189000 USD
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
325000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1462000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11767000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5268000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14301000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12655000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6261000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11709000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6032000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
82000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
130000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12737000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6261000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11839000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6032000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.37
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.37
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1852000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2647000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1891000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2647000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2211000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
919000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
1292000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1594000 USD
us-gaap Gross Profit
GrossProfit
2527000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1259000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4121000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2211000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1835000 USD
us-gaap Gross Profit
GrossProfit
1896000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4121000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD

Files In Submission

Name View Source Status
0001549084-21-000039-index-headers.html Edgar Link pending
0001549084-21-000039-index.html Edgar Link pending
0001549084-21-000039.txt Edgar Link pending
0001549084-21-000039-xbrl.zip Edgar Link pending
ekso-20210630.htm Edgar Link pending
ekso-20210630.xsd Edgar Link pending
ekso-20210630_cal.xml Edgar Link unprocessable
ekso-20210630_def.xml Edgar Link unprocessable
ekso-20210630_htm.xml Edgar Link completed
ekso-20210630_lab.xml Edgar Link unprocessable
ekso-20210630_pre.xml Edgar Link unprocessable
ekso-6302021xex311.htm Edgar Link pending
ekso-6302021xex312.htm Edgar Link pending
ekso-6302021xex321.htm Edgar Link pending
ekso-6302021xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending